ArticleInternational journal of molecular sciences2025
Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs.
Amelia Barilli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.